These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9743592)

  • 1. Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905.
    Li S; Zhang H; Hoff H; Sell C
    Exp Cell Res; 1998 Sep; 243(2):326-33. PubMed ID: 9743592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH; Fleming IN; Downes CP
    Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
    Chen H; Yan GC; Gishizky ML
    Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis.
    Stewart CE; Newcomb PV; Savage PB; Dickens M; Tavare J; Holly JM
    Growth Horm IGF Res; 1999 Apr; 9(2):131-42. PubMed ID: 10373346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
    Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R
    Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anchorage-independent growth of fibroblasts that express a truncated IGF-I receptor.
    Himmelmann B; Terry C; Dey BR; Lopaczynski W; Nissley P
    Biochem Biophys Res Commun; 2001 Aug; 286(3):472-7. PubMed ID: 11511082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
    Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
    Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
    Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
    Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors.
    Merlo GR; Graus-Porta D; Cella N; Marte BM; Taverna D; Hynes NE
    Eur J Cell Biol; 1996 Jun; 70(2):97-105. PubMed ID: 8793381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit.
    Najjar SM; Blakesley VA; Li Calzi S; Kato H; LeRoith D; Choice CV
    Biochemistry; 1997 Jun; 36(22):6827-34. PubMed ID: 9184166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
    Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
    Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.
    Yau L; Lukes H; McDiarmid H; Werner J; Zahradka P
    Eur J Biochem; 1999 Dec; 266(3):1147-57. PubMed ID: 10583412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of MAP kinase in Swiss 3T3 fibroblasts by insulin-like growth factor-I.
    Hansson A; Thorén M
    Growth Regul; 1995 Jun; 5(2):92-100. PubMed ID: 7627095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The insulin receptor: mechanism of activation and message transmission].
    Ballotti R; Tartare S; Van Obberghen E
    Pathol Biol (Paris); 1992 Oct; 40(8):754-62. PubMed ID: 1336594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics of insulin/IGF-I receptor transmembrane signaling.
    Pessin JE; Frattali AL
    Mol Reprod Dev; 1993 Aug; 35(4):339-44; discussion 344-5. PubMed ID: 8398111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
    D'Ambrosio C; Ferber A; Resnicoff M; Baserga R
    Cancer Res; 1996 Sep; 56(17):4013-20. PubMed ID: 8752172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.